by Amit Kini | Jun 11, 2025 | Uncategorized
The use of artificial intelligence in clinical trials is rapidly shifting from experimental to essential. The market for AI in clinical trials is projected to grow at a 12–28% CAGR, with estimates ranging from $1.35–$2.7 billion in 2025 to $3.3–$8.5 billion by 2030....
by Amit Kini | Apr 16, 2025 | Blog
Once a niche for biohackers and wellness influencers, lifestyle medicine and longevity are now mainstream investment themes — and some of the world’s most sophisticated VCs are taking note. The rise in chronic disease, skyrocketing healthcare costs, and a new...
by Amit Kini | Apr 2, 2025 | Blog
Healthcare in the U.S. remains an expensive maze: fragmented networks, unclear billing, redundant care, and stressed-out patients. But as value-based care gains traction, a new class of startups is emerging to solve an old problem — helping people actually use the...
by Amit Kini | Mar 26, 2025 | Blog
While headlines have largely focused on AI and the chill across public markets, biotech is quietly having a moment — just not where most people are looking. Despite the continued freeze in IPO activity, venture capital is still flowing into biotech startups,...
by Amit Kini | Mar 19, 2025 | Blog
Mental health has long been a high-growth vertical in digital health, but the landscape is shifting once again. In a market once dominated by on-demand therapy and meditation apps, we’re now seeing growing investor enthusiasm for startups that navigate care, integrate...
